Focus on Immunizations

Back to articles

9-valent HPV vaccine is safe and well tolerated in girls and boys

KEY POINT

The 9-valent human papillomavirus (9vHPV) vaccine was found to be safe and well tolerated, according to an analysis of seven Phase III studies in patients aged 9 years to 26 years that was published online in Pediatrics.

SOURCES

Moreira ED, et al. Safety profile of the 9-valent HPV vaccine: A combined analysis of 7 Phase III clinical trials. Pediatrics. 2016;[Epub ahead or print].

CDC. Human papillomavirus. Accessed September 25, 2016.